About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists: Human Cases of Infection Could Be Cut by 85 Percent On Vaccinating Cattle Against E. Coli O157

by Rukmani Krishna on September 18, 2013 at 12:28 AM
Font : A-A+

 Scientists: Human Cases of Infection Could Be Cut by 85 Percent On Vaccinating Cattle Against E. Coli O157

Scientists have found that vaccinating cattle against the E. coli O157 bacterium could cut the number of human cases of the disease by 85%.

The bacteria, which cause severe gastrointestinal illness and even death in humans, are spread by consuming contaminated food and water, or by contact with livestock faeces in the environment. Cattle are the main reservoir for the bacterium.

Advertisement

The vaccines that are available for cattle are rarely used, buc could be significant.The research was lead by a team of researchers at the University of Glasgow in collaboration with the University of Edinburgh, the Royal Veterinary College, Scotland's Rural College, Health Protection Scotland, and the Scottish E. coli O157/VTEC Reference Laboratory.

The study, published in the online journal PNAS, used veterinary, human and molecular data to examine the risks of E. coli O157 transmission from cattle to humans, and to estimate the impact of vaccinating cattle.
Advertisement

The risk of E. coli O157 infection is particularly significant when the cattle are 'super-shedding' - excreting extremely high numbers of bacteria in their faeces for a limited period of time. Vaccines against the bacteria exist that can reduce super-shedding. As a consequence, the researchers predict that vaccinating cattle could reduce human cases by nearly 85 percent, far higher than the 50 percent predicted by studies simply looking at the efficacy of current vaccines in cattle.

These figures provide strong support for the adoption of vaccines by the livestock industry, and work is now underway to establish the economic basis for such a programme of vaccination. In addition, research is continuing in Scotland by the same collaborative grouping to develop even more effective vaccines that would further reduce the impact on human disease.

Lead author, Dr Louise Matthews, Senior Research Fellow in the Institute of Biodiversity, Animal Health and Comparative Medicine, said: "E. coli O157 is a serious gastrointestinal illness. The economic impact is also serious - for instance studies in the US suggest that healthcare, lost productivity and food product recalls due to E. coli O157 can cost hundreds of millions of dollars each year.

"Treating cattle in order to reduce the number of human cases certainly makes sense from a human health perspective and, while more work is needed to calculate the cost of a vaccination programme, the public health justification must be taken seriously."

In Scotland, an average of 235 culture positive cases of E. coli O157 infection per year (i.e. people who had the organism in their stools) were notified to Health Protection Scotland from 2008 to 2012.The vaccines that are available currently have poor take-up: one version in the US is not fully licensed because medicines for veterinary use must show that animal health is improved. This is problematic because E. coli O157 does not harm cattle and assessing the impact of treatment involves coordination between human and veterinary health practitioners.

Senior author Professor Stuart Reid of the Royal Veterinary College added: "We increasingly recognise the fact that we share a common environment with the animals we keep - and inevitably the pathogens they harbour. This study is an excellent example the interface between veterinary and human medicine and of the concept of 'One Health' in action - controlling infections in animals can have a major impact on public health."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Flu E. coli Infection / Escherichia coli Infection 
Recommended Reading
E. coli Infection / Escherichia coli Infection
E. coli is a type of gram negative bacteria that lives in the gastrointestinal tract of people and a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use